FDA Considers New Dupilumab Data for CSU Indication ...Middle East

Medscape - News
Additional phase 3 trial results confirmed improvement in hives and itching. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Considers New Dupilumab Data for CSU Indication )

Also on site :

Most viewed in News